Drawing for COLD-FIX

USPTO serial 79216156

COLD-FIX

Reg. 6076998Status 700Renewal
Filing date
Mar 30, 2017
Status date
Jun 16, 2020
Registration date
Jun 16, 2020
Examiner
EVANKO, PATRICIA MALESARDI

Need help with COLD-FIX?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Deadline: June 16th, 2026

Owner

  • Mapix S.à.r.l.

    LU

  • Mapix S.à.r.l

    LU

  • Mapix S.à.r.l

    LU

Goods and services

ClassDescriptionStatusFirst use
005Sanitary preparations for medical purposes; disinfectants; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial, viral and fungal infections, herpes infections, including herpes type I and II, genital herpes, labial herpes and other diseases caused by herpes viruses, namely, varicella and infectious mononucleosis; pharmaceutical preparations for prevention and treatment of enterovirus, rotavirus, coronavirus, adenoviral diseases; pharmaceutical preparations for prevention and treatment of diseases caused by tick-borne encephalitis virus, calicivirus, respiratory viruses; antibody-based pharmaceutical preparations for the treatment of infection diseases; antibody-based pharmaceutical preparations, namely, pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial, viral and fungal infections, herpes infections, including herpes type I and II, genital herpes, labial herpes and other diseases caused by herpes viruses (varicella, infectious mononucleosis); antibody-based pharmaceutical preparations for the prevention and treatment of enterovirus, rotavirus, coronaviruses, adenoviral diseases; antibody-based pharmaceutical preparations to prevent and treat diseases caused by tick-borne encephalitis virus, calicivirus, espiratory viruses; pharmaceutical preparations for the treatment of AIDS/HIV infection; antibody-based pharmaceutical preparations for the treatment of AIDS/HIV infection; pharmaceutical preparations for the treatment of viral hepatitis; antibody-based pharmaceutical preparations for the treatment of viral hepatitis; pharmaceutical preparations for the treatment of influenza; antibody-based pharmaceutical preparations for the treatment of influenza; disinfectants for hygiene purposes, including disinfectants fighting microorganisms which cause infectious disease in man; immunomodulators; anti-mutagenic pharmaceutical preparations for the prevention and treatment of infection diseasesACTIVE

Prosecution history

DateCodeEvent
Jun 16, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 1, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Oct 14, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB
Oct 3, 2020FIMPFINAL DISPOSITION PROCESSED
Sep 16, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 16, 2020R.PRREGISTERED-PRINCIPAL REGISTER
May 8, 2020TMBNTTAB RELEASE CASE TO TRADEMARKS
May 8, 2020OP.TOPPOSITION TERMINATED NO. 999999
May 8, 2020OP.DOPPOSITION DISMISSED NO. 999999
Apr 22, 2020LIMELIMITATION FROM THE IB EXAMINED AND ENTERED
Apr 2, 2020LIMGLIMITATION OF GOODS RECEIVED FROM IB
Mar 1, 2019OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 13, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 13, 2019OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 8, 2018RFNTREFUSAL PROCESSED BY IB
May 17, 2018OP.IOPPOSITION INSTITUTED NO. 999999
May 16, 2018OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB
May 16, 2018OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED
May 4, 2018ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 13, 2018ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Feb 3, 2018GPNXNOTIFICATION PROCESSED BY IB
Jan 16, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 16, 2018PUBOPUBLISHED FOR OPPOSITION
Dec 27, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 27, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 27, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 4, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Dec 1, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 30, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 30, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 18, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 14, 2017RFNTREFUSAL PROCESSED BY IB
Sep 25, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 25, 2017RFRRREFUSAL PROCESSED BY MPU
Sep 20, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 19, 2017CNRTNON-FINAL ACTION WRITTEN
Sep 19, 2017MAFRAPPLICATION FILING RECEIPT MAILED
Sep 13, 2017DOCKASSIGNED TO EXAMINER
Sep 13, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 7, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Related guidance